X4 PHARMACEUTICALS, INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-23.1M | $15.2M |
| FY2017 | — | $-44.5M | $26.7M |
| FY2018 | $8.3M | $-77.1M | $8.1M |
| FY2019 | $20.0M | $129.2M | $126.2M |
| FY2020 | $33.2M | $72.8M | $78.7M |
| FY2021 | $33.1M | $64.4M | $81.8M |
| FY2022 | $32.3M | $74.1M | $121.7M |
| FY2023 | $54.6M | $51.1M | $99.2M |
| FY2024 | $75.0M | $22.1M | $55.7M |
| FY2025 | $75.0M | $186.3M | $217.0M |